FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2636211000001106: Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24917101000001119 Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24917201000001114 Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Is a Mirtazapine 30mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Is pack of Zispin 30mg tablets (Organon Laboratories Ltd) false Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has active ingredient Mirtazapine false Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has AMP Zispin 30mg tablets (Organon Laboratories Ltd) true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zispin 30mg tablets (Organon Laboratories Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start